Amount raised
$35M
Round
Series A
Date raised
November 2, 2026
Founded
—
CompanySpecific Biologics
IndustryBiotechnology
LocationToronto, Canada
InvestorsHatteras Venture Partners
Websitespecificbiologics.com
Leadership
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Specific Biologics
a biotechnology company pioneering a new generation of precision gene-editing therapies for serious genetic diseases
- How much did Specific Biologics raise?
- Specific Biologics raised $35M in a Series A round on November 2, 2026. Investors include Hatteras Venture Partners.
- Who runs Specific Biologics?
- Brent Stead (Chief Executive Officer) is listed as Specific Biologics's officer.
- Where is Specific Biologics based?
- Specific Biologics is based in Toronto, Canada.